Pfizer-BioNTech vaccine delivery could start before Christmas: Company CEO

Vastavam web: The chief executive of German firm BioNTech, which has developed a coronavirus vaccine candidate with American pharmaceutical giant Pfizer, on Wednesday said that the companies could get emergency use authorisation in the United States and Europe in December, Reuters reported. “If all goes well, I could imagine that we gain approval in the second half of December and start deliveries before Christmas, but really only if all goes positively,” Ugur Sahin said.

Sahin told that the firms will seek emergency approval from US on Friday itself. He expressed hope that the coronavirus may be brought under control by the middle of 2021, if everything goes according to the companies’ plans. “Depending on how fast this [review] is really accomplished, we might get an authorization, or conditional approval already in 2020 which might help us start distribution of the first vaccine batches already in 2020,” Sahin said.